Finding a swollen lymph node is alarming. The mind immediately goes to cancer. The reality is more nuanced: the vast majority of swollen lymph nodes are reactive — the immune system doing its job in response to an infection, vaccination, or minor injury. But some swollen lymph nodes are cancer. Knowing which features separate the two is essential knowledge for anyone who discovers a new lump in their neck, armpit, or groin.
This guide explains when swollen lymph nodes are a red flag, which cancers cause lymphadenopathy, which locations are always concerning regardless of size, and what to expect from a proper medical evaluation.
Why Lymph Nodes Swell
Lymph nodes are small, bean-shaped immune organs distributed throughout the body. They filter lymph fluid and serve as immune headquarters: when the body encounters bacteria, viruses, or foreign cells, the nodes in that drainage area enlarge as immune cells proliferate and mount a defense response. This reactive lymphadenopathy is completely normal.
The concern arises when lymph nodes enlarge for reasons other than infection — or when they enlarge and don’t resolve within the expected 2–4 weeks that reactive nodes typically take to return to normal.
Features That Distinguish Concerning Nodes
| Feature | Worrying (possible cancer) | Less Concerning (likely reactive) |
|---|---|---|
| Size | >1.5 cm in peripheral locations | <1 cm, subsiding |
| Consistency | Hard, rubbery, or firm | Soft, spongy |
| Mobility | Fixed, matted to adjacent nodes | Mobile, moves freely |
| Tenderness | Usually non-tender (not absolute) | Often tender (not absolute) |
| Duration | >4–6 weeks without resolution | Resolves within 2–4 weeks |
| Pattern | Progressive enlargement; new nodes appearing | Stable or resolving |
Tenderness alone does not determine whether a lymph node is benign or malignant. Lymphoma nodes can occasionally be tender; reactive nodes are not always tender. Do not use pain as a reassurance tool for swollen lymph nodes.
Locations That Are Always Pathological
Supraclavicular (Above the Collarbone)
This is the single highest-yield location in lymph node evaluation. Any palpable node here — regardless of size — should be investigated as a possible cancer. The location determines which malignancy to suspect:
- Right supraclavicular → drains mediastinum and lungs; suspect lung cancer or mediastinal lymphoma
- Left supraclavicular (Virchow’s node, Troisier’s sign) → drains the thoracic duct receiving lymph from the entire abdomen and pelvis; suspect gastric, pancreatic, colorectal, or ovarian cancer
A palpable left supraclavicular node in a patient with GI symptoms (weight loss, abdominal pain, early satiety) should be evaluated urgently for abdominal malignancy.
Scalene and Popliteal Nodes
Scalene nodes (neck, behind the sternocleidomastoid muscle) are also considered pathological when palpable — they drain the lungs and mediastinum. Popliteal nodes (back of the knee) are rarely palpable in healthy adults; new popliteal adenopathy in the absence of obvious local infection should be evaluated.
Which Cancers Cause Swollen Lymph Nodes?
Cancers Arising FROM the Lymph System
Hodgkin Lymphoma: Classic presentation — painless, rubbery cervical or supraclavicular lymphadenopathy in a young adult (typically 20–35). Nodes are characteristically non-tender and may be associated with B symptoms: fever, night sweats, and >10% weight loss. Mediastinal involvement is common and produces a widened mediastinum visible on chest X-ray.
Non-Hodgkin Lymphoma (NHL): More diverse — can present as localized adenopathy or diffuse disease. Indolent subtypes (follicular lymphoma, CLL/SLL) grow slowly over months to years; aggressive subtypes (DLBCL, mantle cell) cause rapidly enlarging nodes with B symptoms.
Chronic Lymphocytic Leukemia (CLL): Often presents as diffuse, painless lymphadenopathy combined with hepatosplenomegaly and a lymphocytosis on routine blood count. Many patients are diagnosed incidentally during a routine CBC showing high lymphocyte counts.
Cancers That Spread TO Lymph Nodes
Breast cancer: Axillary lymphadenopathy is a key staging determinant. A newly palpable axillary node in a woman — even in the absence of a breast lump — warrants breast imaging.
Lung cancer: Mediastinal and supraclavicular involvement is frequent. Palpable supraclavicular adenopathy is sometimes the first clinical sign, prompting chest imaging that reveals the primary tumor.
Melanoma: Spreads via lymphatics to regional nodes — inguinal from lower extremity, axillary from trunk/arm, cervical from head/neck. In-transit metastases (subcutaneous nodules between primary and regional nodes) are distinctive of melanoma.
Head and neck cancers: Cervical lymph node metastasis sometimes precedes any throat symptoms — the primary tumor in the oropharynx, larynx, or nasopharynx may not be obvious before neck nodes enlarge.
Gastric cancer: Left supraclavicular node (Virchow’s node) is a classic presentation of metastatic gastric cancer — named for the German pathologist Rudolf Virchow who described it in the 19th century.
When to See a Doctor
- Present for more than 4–6 weeks without obvious infection or resolving trend
- Growing or new nodes are appearing
- In the supraclavicular or scalene region (any size)
- Accompanied by B symptoms: fever, night sweats, >10% weight loss
- Hard, fixed, or matted to surrounding tissue
- In a person with a prior cancer history
Biopsy: Which Type Matters
When biopsy is indicated, the type of biopsy matters enormously — particularly for lymphoma:
- Excisional biopsy (remove the whole node): Preferred for lymphoma — preserves internal architecture essential for subclassification. Diagnostic accuracy ~95%.
- Core needle biopsy: Acceptable alternative when excision isn’t feasible; less material, may need repeat.
- Fine needle aspiration (FNA): Adequate for metastatic solid tumors (cytology sufficient). NOT adequate for lymphoma subtyping — do not accept FNA alone if lymphoma is suspected.
Frequently Asked Questions
References
- Chau I, et al. How do I manage lymphadenopathy in adults? Hematology. 2012.
- NCCN Clinical Practice Guidelines: Hodgkin Lymphoma. Version 2024.
- Pangalis GA, et al. Clinical approach to lymphadenopathy. Semin Oncol. 1993.
- Ferrer R. Lymphadenopathy: differential diagnosis and evaluation. Am Fam Physician. 1998;58(6):1313–1320.
- Cheson BD, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007.

